Biological efficacy of twice daily aspirin in type 2 diabetic patients with coronary artery disease.

Background: Diabetes is associated with a high rate of events after acute coronary syndrome and percutaneous coronary intervention despite aspirin treatment. Once daily aspirin might not provide 24-hour stable biological efficacy in patients with diabetes. We compared the biological efficacy of the same daily dose of aspirin given either once (OPD) or divided twice per day in a population of diabetic patients with previous coronary artery disease.

[In-hospital prognosis of right ventricular myocardial infarction].

Aim: To identify prognostic risk factors for in-hospital outcome of right ventricular myocardial infarction (RVI).

Methods: A retrospective study of 20 patients admitted with acute myocardial infarction with a RVI defined by ST segment elevation > or = 1 mm in V3R and V4R leads.

Results: The mean age was 62 years.